Cargando…

The NF-κB Activating Pathways in Multiple Myeloma

Multiple myeloma(MM), an incurable plasma cell cancer, represents the second most prevalent hematological malignancy. Deregulated activity of the nuclear factor kappaB (NF-κB) family of transcription factors has been implicated in the pathogenesis of multiple myeloma. Tumor microenvironment-derived...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roy, Payel, Sarkar, Uday Aditya, Basak, Soumen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027071/ https://www.ncbi.nlm.nih.gov/pubmed/29772694 http://dx.doi.org/10.3390/biomedicines6020059

Ejemplares similares

Immune Differentiation Regulator p100 Tunes NF-κB Responses to TNF
por: Chatterjee, Budhaditya, et al.
Publicado: (2019)

Stimulus-selective crosstalk via the NF-κB signaling system reinforces innate immune response to alleviate gut infection
por: Banoth, Balaji, et al.
Publicado: (2015)

Non-canonical NFκB mutations reinforce pro-survival TNF response in multiple myeloma through an autoregulatory RelB:p50 NFκB pathway
por: Roy, P, et al.
Publicado: (2017)

Targeting NF-κB Signaling for Multiple Myeloma
por: Wong, Ada Hang-Heng, et al.
Publicado: (2020)

Drug Inhibition Profile Prediction for NFκB Pathway in Multiple Myeloma
por: Peng, Huiming, et al.
Publicado: (2011)

Targeting the Non-Canonical NF-κB Pathway in Chronic Lymphocytic Leukemia and Multiple Myeloma
por: Burley, Thomas A., et al.
Publicado: (2022)

PPFIBP1 activates NF-κB signaling to enhance chemoresistance of multiple myeloma
por: Deng, Yi, et al.
Publicado: (2023)

Role of NF-κB Signaling in the Interplay between Multiple Myeloma and Mesenchymal Stromal Cells
por: Cippitelli, Marco, et al.
Publicado: (2023)

IκBβ enhances the generation of the low-affinity NFκB/RelA homodimer
por: Tsui, Rachel, et al.
Publicado: (2015)

IκBɛ provides negative feedback to control NF-κB oscillations, signaling dynamics, and inflammatory gene expression
por: Kearns, Jeffrey D., et al.
Publicado: (2006)

Study on Tim3 Regulation of Multiple Myeloma Cell Proliferation via NF-κB Signal Pathways
por: Liu, Zhaoyun, et al.
Publicado: (2020)

Inhibition of VCP modulates NF-κB signaling pathway to suppress multiple myeloma cell proliferation and osteoclast differentiation
por: Wei, Rongfang, et al.
Publicado: (2023)

A Pathway Switch Directs BAFF Signaling to Distinct NFκB Transcription Factors in Maturing and Proliferating B Cells
por: Almaden, Jonathan V., et al.
Publicado: (2014)

Multiple Myeloma Relapse Is Associated with Increased NFκB Pathway Activity and Upregulation of the Pro-Survival BCL-2 Protein BFL-1
por: Spaan, Ingrid, et al.
Publicado: (2021)

Bone marrow stromal cells from multiple myeloma patients uniquely induce bortezomib resistant NF-κB activity in myeloma cells
por: Markovina, Stephanie, et al.
Publicado: (2010)

Silencing of SENP2 in Multiple Myeloma Induces Bortezomib Resistance by Activating NF-κB Through the Modulation of IκBα Sumoylation
por: Xie, Hongyi, et al.
Publicado: (2020)

Betulinic Acid Induces ROS-Dependent Apoptosis and S-Phase Arrest by Inhibiting the NF-κB Pathway in Human Multiple Myeloma
por: Shen, Min, et al.
Publicado: (2019)

The short-term effect of histone deacetylase inhibitors, chidamide and valproic acid, on the NF-κB pathway in multiple myeloma cells
por: Liu, Zhaoyun, et al.
Publicado: (2019)

KSP inhibitor SB743921 induces death of multiple myeloma cells via inhibition of the NF-κB signaling pathway
por: Song, In-Sung, et al.
Publicado: (2015)

Role of the NFκB-signaling pathway in cancer
por: Xia, Longzheng, et al.
Publicado: (2018)

The NF-κB Pathway and Cancer Stem Cells
por: Rinkenbaugh, Amanda L., et al.
Publicado: (2016)

The NF-κB Nucleolar Stress Response Pathway
por: Thoms, Hazel C., et al.
Publicado: (2021)

S1PR2 Knockdown Promotes Migration and Invasion in Multiple Myeloma Cells via NF-κB Activation
por: Pang, Meng, et al.
Publicado: (2020)

Zinc Chelation Specifically Inhibits Early Stages of Dengue Virus Replication by Activation of NF-κB and Induction of Antiviral Response in Epithelial Cells
por: Kar, Meenakshi, et al.
Publicado: (2019)

RNA demethylase ALKBH5 promotes tumorigenesis in multiple myeloma via TRAF1-mediated activation of NF-κB and MAPK signaling pathways
por: Qu, Jianwei, et al.
Publicado: (2021)

Clinical benefit of ixazomib plus lenalidomide‐dexamethasone in myeloma patients with non‐canonical NF‐κB pathway activation
por: Dash, Ajeeta B., et al.
Publicado: (2020)

Knockdown of long non-coding RNA H19 inhibits multiple myeloma cell growth via NF-κB pathway
por: Sun, Yuanyuan, et al.
Publicado: (2017)

NF-κB Pathways in the Pathogenesis of Multiple Sclerosis and the Therapeutic Implications
por: Leibowitz, Saskia M., et al.
Publicado: (2016)

NF-κB Signaling Pathways in Osteoarthritic Cartilage Destruction
por: Choi, Moon-Chang, et al.
Publicado: (2019)

Small Molecule NF-κB Pathway Inhibitors in Clinic
por: Ramadass, Venkataramanan, et al.
Publicado: (2020)

A novel phosphoramide compound, DCZ0805, shows potent anti-myeloma activity via the NF-κB pathway
por: Gao, Xuejie, et al.
Publicado: (2021)

NF-κB Members Left Home: NF-κB-Independent Roles in Cancer
por: Colomer, Carlota, et al.
Publicado: (2017)

NF-κB, JNK, and TLR Signaling Pathways in Hepatocarcinogenesis
por: Maeda, Shin
Publicado: (2010)

Noncanonical NF-κB Signaling Pathway in Liver Diseases
por: Chen, Qianhui, et al.
Publicado: (2021)

Porcine arterivirus activates the NF-κB pathway through IκB degradation
por: Lee, Sang-Myeong, et al.
Publicado: (2005)

Pirh2 mediates the sensitivity of myeloma cells to bortezomib via canonical NF-κB signaling pathway
por: Yang, Li, et al.
Publicado: (2018)

The combination of HDAC and aminopeptidase inhibitors is highly synergistic in myeloma and leads to disruption of the NFκB signalling pathway
por: Smith, Emma M., et al.
Publicado: (2013)

NF-κB sub-pathways and HIV cure: A revisit
por: Wong, Lilly M., et al.
Publicado: (2020)

Beyond NF-κB activation: nuclear functions of IκB kinase α
por: Huang, Wei-Chien, et al.
Publicado: (2013)

NF-κB pathway activators as potential ageing biomarkers: targets for new therapeutic strategies
por: Balistreri, Carmela R, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_alg1ph4ln21lk36f7pfqdgmv7v